Oral composition for the treatment of inflammatory bowel disease
US5643602A · kind A · utility
75Cited by
5References
26Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 9, 1994 |
| Grant date | Jul 1, 1997 |
| Priority date | — |
| Expiry date | May 9, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/58
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.